American Journal of Kidney Diseases




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Masthead

doi : 10.1053/S0272-6386(22)00599-6

Volume 79, Issue 6, June 2022, Page A3

Buy The Package and View The Article Online




Hematuria and Proteinuria in a Patient With Recurrent Pulmonary Illnesses: A Quiz

Kelly V.Liang1Brigid K.Ellis2Michael B.Stokes3Richard J.Smith4XinGu5Daniel P.Gale6

doi : 10.1053/j.ajkd.2021.10.015

Buy The Package and View The Article Online


COVID-19 Vaccine Refusal and Organ Transplantation

Lainie FriedmanRoss

doi : 10.1053/j.ajkd.2022.02.009

Buy The Package and View The Article Online


COVID-19 Vaccine Mandates for Transplant Patients: Caring for Patients Versus Turning Them Away

KerenLadin12Andrew M.Flescher34Peter P.Reese56

doi : 10.1053/j.ajkd.2022.01.421

Buy The Package and View The Article Online


Dialysis Modality Decisions: Choosing Wisely!

ShiraGoldmanChristopher T.Chan

doi : 10.1053/j.ajkd.2021.10.008

Buy The Package and View The Article Online


Time to Invest in the Future: Assessing the Cost-Effectiveness of Empagliflozin in Diabetic Kidney Disease

AnnikaKhine1JonasKwok2EugeneLin134

doi : 10.1053/j.ajkd.2021.11.003

Buy The Package and View The Article Online


Outscoring Current Classification Systems for Nephrotic Syndrome

GentzonHall12JennieLin34

doi : 10.1053/j.ajkd.2021.12.005

Buy The Package and View The Article Online


Patient Preferences for Longer or More Frequent In-Center Hemodialysis Regimens: A Multicenter Discrete Choice Study

JamesFotheringham13EnricVilar4TarunBansal5PaulLaboi6AndrewDavenport7LoueseDunn3Arne RisaHole2

doi : 10.1053/j.ajkd.2021.09.012

Buy The Package and View The Article Online


Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial

Odette S.Reifsnider1Anuraag R.Kansal1ChristophWanner25EgonPfarr3AudreyKoitka-Weber234Sarah B.Brand1MatthewStargardter1ChengWang5EffieKuti5AnastasiaUstyugova3

doi : 10.1053/j.ajkd.2021.09.014

Buy The Package and View The Article Online


Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome

Jeffrey B.Hodgin1∗Laura H.Mariani2∗JarcyZee58∗QianLiu4Abigail R.Smith4SeanEddy2JohnHartman2HabibHamidi2Joseph P.Gaut9Matthew B.Palmer6Cynthia C.Nast10AnthonyChang11StephenHewitt12Brenda W.Gillespie3MatthiasKretzler2Lawrence B.Holzman7LauraBarisoni1314

doi : 10.1053/j.ajkd.2021.10.004

Buy The Package and View The Article Online


Impact of Bioelectrical Impedance–Guided Fluid Management and Vitamin D Supplementation on Left Ventricular Mass in Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial

K. ScottBrimble1JavierGaname2PeterMargetts1ArshJain5JeffreyPerl6MichaelWalsh134JackieBosch4SalimYusuf24SamyBeshay1WinnieSu8DeborahZimmerman7Shun FuLee4Azim S.Gangji1

doi : 10.1053/j.ajkd.2021.08.022

Buy The Package and View The Article Online


Treatment Effect of Percutaneous Coronary Intervention in Dialysis Patients With ST-Elevation Myocardial Infarction

AkramKawsara1∗SamianSulaiman1∗MohamedMohamed2Timir K.Paul3Kianoush B.Kashani4KhaledBoobes6Charanjit S.Rihal5RajivGulati5Mamas A.Mamas2MohamadAlkhouli5

doi : 10.1053/j.ajkd.2021.08.023

Buy The Package and View The Article Online


CKD Progression From the Time of Estimated GFR-Based Waitlist Eligibility and Racial Disparities in Transplant Access

Chi D.Chu13Neil R.Powe124Deidra C.Crews5Delphine S.Tuot124

doi : 10.1053/j.ajkd.2021.08.010

Buy The Package and View The Article Online


Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study

Orlando M.Gutiérrez1Michael G.Shlipak2RonitKatz4Sushrut S.Waikar5Jason H.Greenberg9Sarah J.Schrauben10StevenCoca11Chirag R.Parikh12Ramachandran S.Vasan6Harold I.Feldman10Paul L.Kimmel13MaryCushman14Joseph V.Bonventre7Mark J.Sarnak8Joachim H.Ix3

doi : 10.1053/j.ajkd.2021.09.018

Buy The Package and View The Article Online


SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes

MinZhuo1245Julie M.Paik1246Deborah J.Wexler7Joseph V.Bonventre24Seoyoung C.Kim134ElisabettaPatorno14

doi : 10.1053/j.ajkd.2021.09.015

Buy The Package and View The Article Online


Recent and Emerging Therapies for Iron Deficiency in Anemia of CKD: A Review

Jonathan W.BazeleyJay B.Wish

doi : 10.1053/j.ajkd.2021.09.017

Buy The Package and View The Article Online


The Role of the Nephrologist in Management of Poisoning and Intoxication: Core Curriculum 2022

Michael E.Mullins1Jeffrey A.Kraut23

doi : 10.1053/j.ajkd.2021.06.030

Buy The Package and View The Article Online


Hypertonic Saline for Hyponatremia: Meeting Goals and Avoiding Harm

HelbertRondon-Berrios1Richard H.Sterns2

doi : 10.1053/j.ajkd.2021.07.020

Buy The Package and View The Article Online


Effect of Policy on Geographic Inequities in Kidney Transplantation

Vishnu S.PotluriRoy D.Bloom

doi : 10.1053/j.ajkd.2021.11.005

Buy The Package and View The Article Online


Moving Toward a Common Pathogenic Mechanism and Therapeutic Targets for APOL1 Nephropathies

Leslie A.Bruggeman1TimurAzhibekov2John F.O’Toole1

doi : 10.1053/j.ajkd.2022.02.011

Buy The Package and View The Article Online


Membranous Nephropathy With Extensive Tubular Basement Membrane Deposits Following Allogeneic Hematopoietic Cell Transplant: A Report of 5 Cases

Samih H.Nasr1NelsonLeung23Samar M.Said1Hassan B.Alkhateeb3Benjamin J.Madden4M. CristineCharlesworth4Laurence H.BeckJr.5Christopher P.Larsen6SanjeevSethi1

doi : 10.1053/j.ajkd.2021.07.021

Buy The Package and View The Article Online


Use of Anticoagulants and Dosing Appropriateness of Apixaban for New-Onset Atrial Fibrillation Among Hemodialysis Patients

MinZhuoMD, MPH1235Julie M.PaikMD, ScD, MPH1245Theodore N.TsacogianisMPH15Rishi J.DesaiPhD15

doi : 10.1053/j.ajkd.2021.08.014

Buy The Package and View The Article Online


Digoxin Dosing and the Risk of Toxicity in Older Adults With CKD

Flory T.MuandaMD, PhD12Matthew A.WeirMD, MSc123FatemehAhmadiPharmD13EricMcArthurMSc1Jessica M.SontropPhD3Richard B.KimMD, FRCPC4Amit X.GargMD, PhD123

doi : 10.1053/j.ajkd.2021.09.024

Buy The Package and View The Article Online


Erratum Regarding “Financial Hardship Among Nonelderly Adults With CKD in the United States� (Am J Kidney Dis. 2021;78[5]:658-668)

doi : 10.1053/j.ajkd.2022.03.001

Buy The Package and View The Article Online


Erratum Regarding “Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study� (Am J Kidney Dis. 2022;79[1]:36-44)

doi : 10.1053/j.ajkd.2022.04.001

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?